Mala Gurbani

Mala Gurbani

Active Director Director DIN 02272564
DIN 02272564 First appointment Nov 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2014
Shareholding value Locked Premium profile

About Mala Gurbani

Data last updated:

Mala Gurbani has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Remedy Health Products Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 02272564
Primary Designation Director
First Appointment 01 Nov 2014
Oldest Company Age 27 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Director01 Nov 20141999Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Remedy Health Products Private Limited
Premium access

Shareholding and investment profile for Mala Gurbani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mala Gurbani

Mala Gurbani has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Remedy Health Products Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Mala Gurbani is associated with 1 company as Director.

Mala Gurbani has expertise in Healthcare.

Mala Gurbani has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available